Definitive Contract 75F40121C00149
Award Date
9/27/21
Potential Completion Date
5/23/23
Potential Value
$566K
Federal Agency
Food and Drug Administration
Ultimate Awardee
State Of California Controllers Office
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,484,606.68 definitive contract awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan to conduct research and analysis on stimulant use, misuse, and use disorder trajectories. The contract has no set-aside designation. Under the contract, the University of Michigan will coordinate with Massachusetts General Hospital and Texas State University to supplement existing drug use and health survey data with clinical data from the MGH's HEAL project....
This federal contract, awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan, is a $2,235,290.00 firm fixed-price definitive contract to conduct a comprehensive study on stimulant and opioid use and use disorder trajectories and associated consequences in U.S. adults. The contract does not have a set-aside designation. The University of Michigan, as the prime contractor, will leverage its extensive research capabilities to carry out this study. Two...
This is a $3,701,150.34 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the Regents of the University of California, San Francisco (UCSF) under the BAA EETWP 65 - Community Uses of Psychedelics and Safety Study (CUPS) program. The contract is not set aside for any particular business type. UCSF, the prime contractor, has subcontracted with Oregon Health & Science University, Legacy Emanuel Hospital & Health Center, and Kaiser Foundation Hospitals to collect...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $150,000 firm-fixed-price purchase order to The Regents of the University of California, San Francisco (UCSF) for design consulting services related to a field test battery for the Research Domain Criteria (RDoC) program. The contract does not have a set-aside designation. UCSF is a prominent academic institution that frequently partners with federal agencies to conduct biomedical...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to The Regents of the University of California, San Francisco (UCSF) for the Center for Drug Evaluation and Research (CDER) - Office of Executive Programs (OEP) Division of Learning and Organizational Development (DLOD) Drug Development and Regulatory Sciences Course. The $175,000.00 contract has a completion date of December 31, 2022. UCSF, a U.S. state government and educational...
This federal contract award is for biomedical research and services, with a total ceiling value of $10,607,389.80. The contract was awarded on March 28, 1996 to the prime contractor, The Regents of the University of California, San Francisco (UCSF), and has an ultimate completion date of February 14, 2013. The contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract is a definitive...
This is a $695,510 firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Drug Enforcement Administration (DEA) to The Regents of the University of California, San Francisco (UCSF). The contract is for toxicological testing of overdose samples over a 1-year period of performance from February 10, 2025 to February 9, 2026, with a total completion date of March 9, 2026. UCSF is a leading academic medical center and research institution that receives significant federal funding,...
This $89,701.75 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to the Regents of the University of California, San Francisco (UCSF) on August 28, 2023. The contract is for exposure to illicit drugs urine analysis services, with a period of performance running through April 22, 2025. UCSF is a prominent academic medical center and research institution that has demonstrated significant capabilities in securing federal contracts and grants across...
This federal contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to The Regents of the University of California, San Francisco (UCSF). The contract, valued at $2,630,077.20, is for a STUDY/CHEMICAL-BIOLOGICAL project with a performance period ending on June 30, 2007. UCSF is a leading academic medical center and research institution that frequently partners with federal agencies like the NIDDK to conduct biomedical research,...
This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call contract awarded by the Food and Drug Administration (FDA) to Research Triangle Institute (RTI International), a non-profit research organization, for $893,433.00. The contract is for exploring the knowledge and drug preferences of individuals injecting prescription opioids or prescription stimulants. There is no set-aside designation. The contract includes a subcontract to the University of North Carolina at Chapel Hill (UNC-CH)...